Mizuho cuts target to USD 80 for Alcon stock

Published on 10/15/2026 at 10:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Mizuho cut its target to USD 80 from USD 85 on October 13, 2026. Alcon stock costs EUR 57.63 on October 15, 2026.

Analyst view and company scale

Mizuho cut its Alcon target from USD 85.00 to USD 80.00 on October 13, 2026.
Alcon serves patients in more than 140 countries with over 25,000 associates.
Alcon stock trades at EUR 57.63 at 10:38 a.m. CEST at Lang & Schwarz on October 15, 2026.

Bauhaus style graphic design poster in wide horizontal format. Geometric stylized eye centered, iris as concentric circles and radial lines in primary red, blue, yellow on cream white, heavy black outlines, flat bold shapes, no gradients — Alcon CH0432492467: Bauhaus Poster mit geometrischem Auge und Linse in den Primärfarben Rot und Blau, Illustration mit AI erstellt.

Alcon (ISIN CH0432492467) was trading at EUR 57.63 at Lang & Schwarz on October 15, 2026 at 10:38 a.m. CEST. Mizuho cut its price target for Alcon from USD 85.00 to USD 80.00 on October 13, 2026, while keeping an Outperform rating, according to Markets Insider.

Mizuho trims its target

The change came in a research preview of Alcon's third-quarter results. Mizuho cited expected procedure-volume headwinds linked to the Affordable Care Act and a contraction in Medicaid coverage, according to the October 13 report. The revised target remains above the latest US-listed reference level cited in the report, but the cut signals a more cautious earnings setup.

What does USD 80 mean?

The target adjustment puts operating trends ahead of broad medical-device sentiment. Alcon's second-quarter revenue was USD 2.82 billion, while diluted earnings per share were USD 0.84, according to the company's investor-relations coverage of the period. Those figures give the target revision a specific operating backdrop rather than making it only a valuation call.

Alcon's operating scale

Alcon describes itself as an eye-care company with a portfolio spanning surgical and vision-care products. Its products serve people in more than 140 countries, and the company has over 25,000 associates, according to Alcon. The breadth of that footprint matters because procedure volumes and access to care affect both major business lines.

For investors, the immediate question is whether the next reported period can support the company's scale. Mizuho's target cut supplies a dated counterpoint to Alcon's global reach and keeps attention on procedure demand, public-health coverage and quarterly execution.

Stock price in euros

The euro quotation was intraday at Lang & Schwarz on October 15, 2026. The latest analyst action was dated October 13, 2026, and the company facts relate to the second quarter of 2026.

The further course of trading is shown by the continuously updated real-time quote of Alcon stock.